7 Results for "

epoxyketone

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "epoxyketone" in MCE Product Catalog:

27
27 Cited Publications
Cat. No.: HY-13821
CAS No.: 134381-21-8
Purity:  99.39%
Synonyms: BU-4061T
Epoxomicin (BU-4061T) is an epoxyketone-containing natural product and a potent, selective and irreversible proteasome inhibitor. Epoxomicin covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome and potently inhibits primarily the chymotrypsin-like activity. Epoxomicin can cross the blood-brain barrier. Epoxomicin has strongly antitumor and anti-inflammatory activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12113
CAS No.: 935888-69-0
Purity:  99.76%
Synonyms: ONX 0912; PR-047
Research Areas:  

Cancer

Oprozomib (PR-047) is an orally bioavailable and selective peptide epoxyketone proteasome inhibitor with IC50s of 36 and 82 nM for proteasome (β5) and immunoproteasome (LMP7), respectively. Oprozomib (ONX 0912) induces apoptosis in MM cells .
loading...
    loading...
Cat. No.: HY-123587
CAS No.: 1416709-79-9
Purity:  98.87%
Target:  

Proteasome Apoptosis

Research Areas:  

Cancer

PR-924 is a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor with an IC50 of 22 nM. PR-924 covalently modifies proteasomal N-terminal threonine active sites. PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities .
loading...
    loading...
Cat. No.: HY-123587A
Purity:  98.50%
Target:  

Apoptosis

Research Areas:  

Cancer

(R)-PR-924 is the isomer of PR-924 (HY-123587), and can be used as an experimental control. PR-924 is a selective tripeptide epoxyketone immunoproteasome subunit LMP-7 inhibitor with an IC50 of 22 nM. PR-924 covalently modifies proteasomal N-terminal threonine active sites. PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities .
loading...
    loading...
Cat. No.: HY-168902
Target:  

Proteasome

Research Areas:  

Cancer

Proteasome-IN-7 (Compound 6f) is an epoxyketone macrocyclic peptidyl proteasome inhibitor (IC50 value of 37.92 nM for 20S proteasome ChT-L subunit). Proteasome-IN-7 displays robust antiproliferative effects against multiple myeloma, acute lymphoblastic leukemia and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P11311
CAS No.: 1356828-46-0
Target:  

Proteasome

Research Areas:  

Cancer

NC-002, a cell-permeable peptide, is a Trypsin-like proteasome inhibitor without inhibition of lysosomal cysteine proteases. NC-002 is the epoxyketone derivative of Leupeptin (HY-18234). NC-002 sensitizes myeloma cells to Bortezomib (HY-10227) and Carfilzomib (HY-10455). NC-002 can be used for cancers research .
loading...
    loading...
Cat. No.: HY-184919
CAS No.: 3056058-96-6
Target:  

Proteasome

Research Areas:  

Neurological Disease

LMP2-IN-1 is an orally bioavailable, brain-permeable macrocyclic peptide epoxyketone, acts as a selective and irreversible inhibitor of LMP2 (IC50 = 87 nM). LMP2-IN-1 rapidly distributes to the brain and forms an irreversible LMP2:AR-01 adduct. LMP2-IN-1 improves memory function and rescues reactive astrocytes in 5xFAD mouse models of Alzheimer's disease (AD) .
loading...
    loading...